-transparent.png){kind=logo}
The influence of various test meals and ingested fluid volumes on the bioavailability and pharmacokinetics of propoxyphene and its major metabolite norporpoxyphene has been studied in healthy human subjects. The absorption of drug was delayed by all test meals, but the overall efficiency of absorption was either not affected or was slightly increased. Increased fluid volume intake decreased propoxyphene bioavailability. Plasma levels of metabolite correlated well with levels of unchanged drug, particularly in the first 2 hr after dosing, but were not markedly influenced by treatments.
Related Publications
P G Welling, and
L L Lyons, and
F L Tse, and
W A Craig
February 1977,
Journal of chromatography,
P G Welling, and
L L Lyons, and
F L Tse, and
W A Craig
May 1980,
Clinical pharmacology and therapeutics,
P G Welling, and
L L Lyons, and
F L Tse, and
W A Craig
May 1986,
Acta anaesthesiologica Scandinavica,
P G Welling, and
L L Lyons, and
F L Tse, and
W A Craig
January 1985,
Journal of pharmaceutical sciences,
P G Welling, and
L L Lyons, and
F L Tse, and
W A Craig
February 1982,
Clinical pharmacology and therapeutics,
P G Welling, and
L L Lyons, and
F L Tse, and
W A Craig
November 1980,
Journal of pharmaceutical sciences,
P G Welling, and
L L Lyons, and
F L Tse, and
W A Craig
October 1975,
Archives of toxicology,
P G Welling, and
L L Lyons, and
F L Tse, and
W A Craig
May 1984,
Clinical pharmacology and therapeutics,
P G Welling, and
L L Lyons, and
F L Tse, and
W A Craig
September 1980,
Clinical pharmacology and therapeutics,
P G Welling, and
L L Lyons, and
F L Tse, and
W A Craig
January 1974,
Drug metabolism and disposition: the biological fate of chemicals,
